Fermenta Biotech Limited (FERMENTA)
Press release regarding unaudited financial results of Q1FY27.
Press Release - Q1FY27
- Consolidated revenue INR 126.2 crore, down 13% YoY, flat QoQ
- EBITDA INR 22.4 crore, down 39% YoY, down 11% QoQ
- Profit after tax INR 9.5 crore, down 56% YoY, down 49% QoQ
- Human nutrition volumes up 18% QoQ; India revenue share rose to 47%
- VITADEE Green® received FSSAI approval post quarter-end, expanding market
- Animal nutrition volumes and realizations declined; other segments showed growth
- No exceptional items in Q1FY27; prior quarter included non-recurring income
- Company launched nationwide Vitamin D deficiency awareness campaign
- German and US subsidiaries reported revenue declines; environment segment loss widened
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 FERMENTA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add FERMENTA to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Fermenta Biotech Limited
Important.
The summary above is generated automatically from Fermenta Biotech Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.